Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 99

Results For "AIM"

1755 News Found

Apex laboratories introduces OVAPEX Tablets for managing PCOS & female infertility
News | July 05, 2023

Apex laboratories introduces OVAPEX Tablets for managing PCOS & female infertility

OVAPEX is a unique formula developed by the team of scientists and doctors at Green Milk Concepts


BDR Pharma's Nilotinib sets a new standard in the treatment of Philadelphia Chromosome-positive leukaemia
News | July 05, 2023

BDR Pharma's Nilotinib sets a new standard in the treatment of Philadelphia Chromosome-positive leukaemia

Rare childhood cancer subtype, Ph+ ALL, is found in 3-4% of pediatric cases and 25% of adult cases


Sanofi reaffirms ambition to deliver >€10bn in annual vaccines sales by 2030
News | July 03, 2023

Sanofi reaffirms ambition to deliver >€10bn in annual vaccines sales by 2030

Intent to start at least 5 innovative Phase 3 vaccine programs by 2025


Merck to expand reagent production capacity in China
News | June 30, 2023

Merck to expand reagent production capacity in China

The €70 million investment will allow the large-scale manufacturing of high-purity reagents for quality control and testing for biopharma customers, increasing annual output by several thousand tons


GenWorks Health launches IVD tests for dengue and malaria
Healthcare | June 29, 2023

GenWorks Health launches IVD tests for dengue and malaria

Rapid card test kits for iScreen malaria card antigen (Pf/Pv) & iScreen dengue NS1


Granules India and Central Bureau of Narcotics unite to tackle drug abuse
News | June 29, 2023

Granules India and Central Bureau of Narcotics unite to tackle drug abuse

Granules India sponsored an initiative to ignite a drug-free revolution and contribute towards an empowered society


AstraZeneca announces US$400 million investment in reforestation and biodiversity
News | June 28, 2023

AstraZeneca announces US$400 million investment in reforestation and biodiversity

New reforestation projects in Brazil, India, Vietnam, Ghana and Rwanda in addition to existing projects including in Australia and Indonesia


Boehringer Ingelheim and Zealand Pharma Phase II trial with survodutide shows nearly 19% weight loss in people with obesity
News | June 28, 2023

Boehringer Ingelheim and Zealand Pharma Phase II trial with survodutide shows nearly 19% weight loss in people with obesity

Survodutide has a novel mechanism of action (agonism of the dual GCG/GLP-1 receptors) that may have direct effects on energy expenditure in the liver in addition to decreasing appetite


Oncodesign Services announce access to ImaginAb’s CD8 ImmunoPET technology
News | June 28, 2023

Oncodesign Services announce access to ImaginAb’s CD8 ImmunoPET technology

Oncodesign Services and ImaginAb sign a Preclinical License and Supply Agreement


GSK receives USFDA Fast Track designation for investigational vaccine against gonorrhoea
News | June 28, 2023

GSK receives USFDA Fast Track designation for investigational vaccine against gonorrhoea

Currently there are no vaccines approved anywhere in the world for gonorrhoea, and antimicrobial resistance to existing treatments is increasing